Viromed Medical AGXTER:VME -2.04%15 Beneish M-Score is 0.85 as of Jun. 26, 2026, which is at its 10-year median of 0.85. GuruFocus rates XTER:VME with a GF Score™ of 15/100. The stock has 5 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Viromed Medical AG ranks worse than 95.3% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Warning Sign:
Beneish M-Score 0.85 higher than -1.78, which implies that the company might have manipulated its financial results.
The historical rank and industry rank for Viromed Medical AG's Beneish M-Score or its related term are showing as below:
XTER:VME'
s Beneish M-Score Range Over the Past 10 Years
Min: 0.85 Med: 0.85 Max: 0.85
Current: 0.85
During the past 5 years, the highest Beneish M-Score of Viromed Medical AG was 0.85. The lowest was 0.85. And the median was 0.85.
Viromed Medical AG Beneish M-Score Related Terms
Viromed Medical AG Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:VME vs ABT, SYK, MDT: Beneish M-Score Comparison
For the Medical Devices subindustry, Viromed Medical AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Viromed Medical AG for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 1.3076
+
0.528 * -0.5699
+
0.404 * 1.6949
+
0.892 * 4.5218
+
0.115 * 2.3366
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1
+
4.679 * 0.043481
-
0.327 * 0.6986
=
0.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(0.254 / (0.254 + 0.119))
/
(0.524 / (0.524 + 1.274))
=
0.680965
/
0.291435
=
2.3366
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(0.605 - 0
-
0)
/
13.914
=
0.043481
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Viromed Medical AG has a M-score of 0.85 signals that the company is likely to be a manipulator.
Viromed Medical AG (XTER:VME) has a Beneish M-Score of 0.85 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Viromed Medical AG and its competitors. This is near median its historical median of 0.85. Over the past decade, Viromed Medical AG's Beneish M-Score has ranged from 0.85 to 0.85. According to the industry distribution chart, Viromed Medical AG ranks #730 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 95.3%.
Is Viromed Medical AG's Beneish M-Score too high?
Viromed Medical AG's current Beneish M-Score of 0.85 is near median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 0.85. Based on the distribution chart, Viromed Medical AG ranks #730 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Viromed Medical AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #730 out of 766 companies for Beneish M-Score. This places Viromed Medical AG in the lower half of its industry. Historically, Viromed Medical AG's own Beneish M-Score has ranged from 0.85 to 0.85 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Viromed Medical AG and its competitors. Viromed Medical AG's current Beneish M-Score is 0.85, which is near median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Beneish M-Score of 0.85. The current Beneish M-Score is 0.85, which is near median its 10-year median of 0.85. Viromed Medical AG's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Beneish M-Score is 0.85 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
15GF Score
Get the complete analysis for XTER:VME
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:VME has been successfully added to your 
